Stock Quote

Edwards Lifesciences Corporation (EW) (NYSE Arca)
As of  3:18pm EST
81.22USD
Price Change
-0.03
Percent Change
-0.04%
 
$81.22
3:18pm EST
-0.04%
$81.25
$81.32
163,699
$82.13
$80.96
$81.99
$45.06
0.45
261,987

Research Another Stock: Symbol Look-up
Medical device prices in crosshairs of reform
Thursday, 12 Nov 2009 02:26pm EST 
Edwards sees sales growth over 10 percent
Wednesday, 11 Nov 2009 02:54pm EST 
Device sector resigned to U.S. reform taxes
Wednesday, 11 Nov 2009 01:33pm EST 
Edwards Lifesciences Corporation Q3 2009 Earnings Call Transcript
Wednesday, 21 Oct 2009 10:31pm EDT(Seeking Alpha) 
Notable Market Action: October 13, 2009
Wednesday, 14 Oct 2009 07:24am EDT(Seeking Alpha) 
Best Performing Mid and Small Cap Stocks Since 10/9/07 Peak
Friday, 9 Oct 2009 11:29am EDT(Seeking Alpha) 
Mindray Rides Hot Trends: Under the Radar
Wednesday, 30 Sep 2009 05:00am EDT(The Street) 
 
Name Current Position Compensation
Mussallem, Michael Chairman of the Board, Chief Executive Officer 4,634,270
Abate, Thomas Chief Financial Officer, Corporate Vice President, Treasurer 1,135,250
Garren, Bruce Corporate Vice President - Government Affairs, General Counsel --

Profile

Edwards Lifesciences Corporation (Edwards Lifesciences) is a global player in products and technologies designed to treat cardiovascular disease. The Company is focused specifically on technologies that treat structural heart disease and critically ill patients. The products and technologies... Full Description

Company Address

Edwards Lifesciences Corporation
One Edwards Way
Irvine   CA   92614
P: +1949.2502500
F: +1949.2502525

Analyst Research

Performance of Key Competitors

Company Price Change
St. Jude Medical, Inc. $35.04 +0.72
Medtronic, Inc. $40.20 +0.58
Sorin SpA €1.29 +0.06
  EW Industry
P/E(TTM) 21.81 3.76
P/S(TTM) 3.58 0.51
ROI(TTM) 17.87 2.54
ROE(TTM) 22.35 4.01
Consensus Recommendation Outperform
EPS Est. (Current Period) 0.82
EPS Est. (Current Year) 3.05
Total Revenue $325.70M
Net Income $73.50M
EPS $1.25